Smart jab can shrink head and neck cancer tumours within six weeks, trial finds
Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancers Doctors have hailed “incredibly encouraging” trial results that show a triple-action smart jab can shrink tumours in head and neck cancer patients within six weeks. Head and neck (…)
Site référencé:
The Guardian (Africa)
3566.jpg?width=140&quality=85&auto=format&fit=max&s=6b8d8aa1d243e52630ec912240d7c64f, 3566.jpg?width=460&quality=85&auto=format&fit=max&s=2d87713509e54a6825bcd7efa979683a, 3566.jpg?width=700&quality=85&auto=format&fit=max&s=0f55e3e23cd4fdddf1f92afd52d64c83
The Guardian (Africa)
China’s economic growth hits one-year low as house prices fall again – business live
20/10/2025
New Zealand v England : second men’s T20 international – live
20/10/2025
The Uncool by Cameron Crowe review – inside rock’s wildest decade
20/10/2025
I’m still globetrotting at 76. New people and new places are what keep me alive
20/10/2025
AI-generated ‘poverty porn’ fake images being used by aid agencies
20/10/2025
Wilfred Buck review – rewarding life of Indigenous American astronomer laid out in the stars
20/10/2025